BioMarin Pharmaceuticals Inc (BMRN) is a publicly traded Healthcare sector company. As of July 2, 2026, BMRN trades at $58.85 with a market cap of $11.06B and a P/E ratio of 41.27. BMRN moved +1.92% today. Year to date, BMRN is -2.74%; over the trailing twelve months it is +2.90%. Its 52-week range spans $49.26 to $73.51. Analyst consensus is strong buy with an average price target of $87.00. Rallies surfaces BMRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioMarin Pharmaceuticals Inc (BMRN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BMRN moved +1.92% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $58.85 |
| Market Cap | $11.06B |
| P/E Ratio | 41.27 |
| EPS | $1.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $73.51 |
| 52-Week Low | $49.26 |
| Volume | 456.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.24B |
| Net Income | $268.74M |
| Gross Margin | 76.53% |
20 analysts cover BMRN: 0 strong buy, 15 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.00.